Therapeutic drug monitoring
-
Randomized Controlled Trial Multicenter Study
Determinants of adherence to delayed-release doxylamine and pyridoxine in patients with nausea and vomiting of pregnancy.
Women often hesitate to take medications in pregnancy due to fears of perceived potential fetal damage. The authors' objective is to identify the determinants of adherence to delayed-release doxylamine-pyridoxine (Diclectin) in patients with nausea and vomiting of pregnancy (NVP). ⋯ Adherence to antinauseants for NVP is affected by number of tablets prescribed per day, and treatment duration and effectiveness.